Parkinson’s Disease drug sales to nearly double by 2025.
Datamonitor Healthcare estimates that Parkinson’s disease sales will grow substantially in the US, Japan, and five major EU markets, expanding from $3.2bn in 2016 to $6.0bn in 2025.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: